43406-0120 NDC - FUNGUS NOSODE (ACHORION SCHO, ALTERNARIA ALT, ASPERGILLUS FUM, ASPERGILLUS NIGER, BOLETUS SAT, BOTRYTIS CIN, CANDIDA PARAP, CLADOSPORIUM MET, FUSARIUM OXY, HELMINTHOSPORIUM SAT, MICROSPORON FUR, MUCOR MUECEDO, PULLULARIA PULL, RHIZOPUS NIG, SACCHAROMYCES CER, TRICHOPHYTON SPP, USTILAGO MAYDIS)

Drug Information

Product NDC: 43406-0120

Proprietary Name: Fungus Nosode

Non Proprietary Name: Achorion Scho, Alternaria Alt, Aspergillus Fum, Aspergillus Niger, Boletus Sat, Botrytis Cin, Candida Parap, Cladosporium Met, Fusarium Oxy, Helminthosporium Sat, Microsporon Fur, Mucor Muecedo, Pullularia Pull, Rhizopus Nig, Saccharomyces Cer, Trichophyton Spp, Ustilago Maydis

Active Ingredient(s):
  • 200 [hp_X]/mL ALTERNARIA ALTERNATA;
  • 200 [hp_X]/mL ASPERGILLUS FUMIGATUS;
  • 200 [hp_X]/mL ASPERGILLUS NIGER VAR. NIGER;
  • 200 [hp_X]/mL AUREOBASIDIUM PULLULANS VAR. PULLUTANS;
  • 200 [hp_X]/mL BOLETUS SATANAS FRUITING BODY;
  • 200 [hp_X]/mL BOTRYTIS CINEREA;
  • 200 [hp_X]/mL CANDIDA PARAPSILOSIS;
  • 200 [hp_X]/mL COCHLIOBOLUS SATIVUS;
  • 200 [hp_X]/mL EPIDERMOPHYTON FLOCCOSUM;
  • 200 [hp_X]/mL FUSARIUM OXYSPORUM;
  • 200 [hp_X]/mL HORTAEA WERNECKII;
  • 200 [hp_X]/mL RHIZOPUS STOLONIFER;
  • 200 [hp_X]/mL SACCHAROMYCES CEREVISIAE RNA;
  • 200 [hp_X]/mL TRICHOPHYTON SCHOENLEINII;
  • 200 [hp_X]/mL USTILAGO MAYDIS


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC]

Labeler Information

Labeler Name: Natural Creations, Inc
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:12/15/2011

Package Information

No. Package Code Package Description Billing Unit
143406-0120-130 mL in 1 BOTTLE, DROPPER (43406-0120-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43406-0120The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEFungus NosodeThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAchorion Scho, Alternaria Alt, Aspergillus Fum, Aspergillus Niger, Boletus Sat, Botrytis Cin, Candida Parap, Cladosporium Met, Fusarium Oxy, Helminthosporium Sat, Microsporon Fur, Mucor Muecedo, Pullularia Pull, Rhizopus Nig, Saccharomyces Cer, Trichophyton Spp, Ustilago MaydisThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE12/15/2011This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENatural Creations, IncName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOLETUS SATANAS FRUITING BODY; BOTRYTIS CINEREA; CANDIDA PARAPSILOSIS; COCHLIOBOLUS SATIVUS; EPIDERMOPHYTON FLOCCOSUM; FUSARIUM OXYSPORUM; HORTAEA WERNECKII; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE RNA; TRICHOPHYTON SCHOENLEINII; USTILAGO MAYDISAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023